DVAX Chart
- 52-Week Range: $7.45 - $20.94
- Market Capitalization: $1.44B
- Short Percentage: 0%
- Target Price: $26.25
- Shares Outstanding: 126.31M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
DVAX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Valneva Initiates Heterologous Booster Trial of Inactivated, COVID-19 Vaccine CandidateGlobeNewsWire | May 4th
- Clover's Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious DiseaseGlobeNewsWire | April 20th
Company Info
Website: https://www.dynavax.com
Address: 2100 Powell Street, EmeryVille, CA, United States, 94608
Sector: Healthcare
Industry: Biotechnology
Full time employees: 311
Address: 2100 Powell Street, EmeryVille, CA, United States, 94608
Sector: Healthcare
Industry: Biotechnology
Full time employees: 311
$DVAX buy SHARES
$DVAX we just getting started
$DVAX shorting it
$DVAX I hate this company.
$DVAX we going up from here
$DVAX i come here all weekend... every weekend. refresh refresh refresh. smh
$DVAX diversified
$DVAX News Plz.....
$DVAX I do it for the thrills!
$DVAX Short again!! 😀 😀